Use of Omalizumab for Pediatric Asthma After US Food and Drug Adminstration Expanded Indications

Publication Title

Pharmacoepidemiology and Drug Safety

Authors

Anjali D. Deshmukh, Georgia State College of LawFollow
Aaron S. Kesselheim, Brigham and Women's Hospital, Harvard Medical SchoolFollow
Theodore Tsacogianis, Brigham & Women's Hospital
Benjamin N. Rome, Brigham and Women's Hospital

Document Type

Article

Publication Date

2024

Recommended Citation

Anjali Deshmukh, et al., Use of Omalizumab for Pediatric Asthma After US Food and Drug Administration Expanded Indications, 33 Pharmacoepidemiology and Drug Safety E70009 (2024).

Institutional Repository Citation

Anjali D. Deshmukh, Aaron S. Kesselheim, Theodore Tsacogianis & Benjamin N. Rome, Use of Omalizumab for Pediatric Asthma After US Food and Drug Adminstration Expanded Indications, Faculty Publications By Year 3655 (2024)
https://readingroom.law.gsu.edu/faculty_pub/3655

DOI

10.1002/pds.70009

Volume

33